Technical Analysis for AGTC - Applied Genetic Technologies Corporation

Grade Last Price % Change Price Change
grade F 3.8 3.26% 0.12
AGTC closed up 3.26 percent on Friday, May 24, 2019, on 88 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AGTC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 3.26%
NR7 Range Contraction 3.26%
Outside Day Range Expansion 2.15%
NR7 Range Contraction -0.52%
Inside Day Range Contraction -0.52%
Lower Bollinger Band Walk Weakness 1.06%
Lower Bollinger Band Touch Weakness 1.06%

Older signals for AGTC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. The company also completed preclinical proof-of-concept studies, and Phase I and Phase II clinical trials of a treatment for alpha-1 antitrypsin deficiency, an inherited orphan lung disease. In addition, it has proof-of-concept programs for other eye diseases, such as leber congenital amaurosis (type 2), and wet form of age-related macular degeneration. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.
Biotechnology Medical Specialties Diseases Gene Therapy Ophthalmology Age Related Macular Degeneration Vision Retinitis Pigmentosa Antitrypsin Deficiency Eye Diseases Gene Therapy Products X Linked Retinitis Pigmentosa Retinoschisis
Is AGTC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.5
52 Week Low 2.26
Average Volume 62,803
200-Day Moving Average 4.5895
50-Day Moving Average 4.29
20-Day Moving Average 4.0605
10-Day Moving Average 3.833
Average True Range 0.2586
ADX 31.31
+DI 19.1315
-DI 28.573
Chandelier Exit (Long, 3 ATRs ) 4.1742
Chandelier Exit (Short, 3 ATRs ) 4.3158
Upper Bollinger Band 4.5716
Lower Bollinger Band 3.5494
Percent B (%b) 0.25
BandWidth 25.17424
MACD Line -0.1716
MACD Signal Line -0.135
MACD Histogram -0.0366
Fundamentals Value
Market Cap 68.73 Million
Num Shares 18.1 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 6.03
Price-to-Sales 1.74
Price-to-Book 0.60
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.31
Resistance 3 (R3) 4.35 4.22 4.23
Resistance 2 (R2) 4.22 4.09 4.20 4.20
Resistance 1 (R1) 4.01 4.01 4.12 3.97 4.17
Pivot Point 3.88 3.88 3.93 3.86 3.88
Support 1 (S1) 3.67 3.75 3.78 3.63 3.43
Support 2 (S2) 3.54 3.67 3.52 3.40
Support 3 (S3) 3.33 3.54 3.38
Support 4 (S4) 3.29